When a medical practice depends on an EHR platform every single day, even a rumor about the vendor’s stability can cause real anxiety. Searches for “Is Greenway Health going out of business” have been growing, and that question deserves a clear, honest answer.
This article covers what Greenway Health actually is, what the evidence shows about its current status, the context behind its legal history and layoffs, and what the shift to a new platform called Novare means for existing customers.
What Greenway Health Does and Who Owns It
Greenway Health is a privately held U.S. health IT company headquartered in Tampa, Florida, with additional offices in Bangalore, India. It develops electronic health record (EHR), practice management, and revenue cycle management software specifically for ambulatory, or outpatient, practices.
Its two core legacy products are Intergy and PrimeSUITE. These systems have served physician offices and outpatient clinics for years.
The company took its current form in 2013 when Greenway Medical Technologies combined with Vitera Healthcare Solutions. That same year, Vista Equity Partners, a major private equity firm, acquired Greenway Medical Technologies and took it private.
That ownership detail matters. Private equity firms acquire companies because they expect to generate value from them over time. That is not the behavior of an investor preparing to shut something down. It does, however, explain some of the cost-cutting and restructuring patterns that employees and customers have noticed over the years.
No, Greenway Health Is Not Going Out of Business
There is no public bankruptcy filing, no wind-down announcement, and no official closure notice from Greenway Health as of the available current information.
Greenway’s website actively promotes EHR software and AI-driven solutions for ambulatory practices. The company is marketing to new customers, supporting existing ones, and publicly discussing its next-generation platform. That is not what a company on the verge of closing looks like.
The more accurate picture is this: Greenway is in transition, not in collapse. There is a meaningful difference between the two, and understanding that difference matters for anyone currently using their software.
It is also worth noting that forum speculation and anonymous reviews online are not reliable evidence of a company closing. They are worth reading for context, but they should not be treated as fact without supporting documentation.
The DOJ Settlement and What It Actually Meant
The most significant factual event that likely drives concern about Greenway is its 2019 legal settlement with the federal government.
In 2019, Greenway Health agreed to pay $57.25 million to resolve federal allegations. The Department of Justice alleged that Greenway caused its EHR users to submit false claims for incentive payments under the HITECH Act, and that it violated the Anti-Kickback Statute. Specifically, the DOJ alleged that Greenway misrepresented PrimeSUITE’s capabilities in relation to “meaningful use” certification requirements.
As part of the resolution, Greenway entered into a Corporate Integrity Agreement with the HHS Office of Inspector General, requiring compliance oversight for a defined period.
This was a serious matter. It damaged Greenway’s reputation and likely shook confidence among customers. But it did not put the company out of business. Greenway paid the settlement, accepted the compliance obligations, and continued operating.
Readers evaluating Greenway today should treat this as important historical context. It should inform due diligence. It should not, however, be equated with an ongoing legal crisis or an indication that the company is about to close.
Layoffs and Employee Concerns: What They Actually Signal
Multiple employee reviews on Glassdoor and Indeed describe layoffs, surprise workforce reductions, and what some describe as an annual restructuring pattern. Reviews also mention limited salary growth and general management concerns.
This is real feedback and worth taking seriously. But it needs proper context.
Private equity-owned software companies commonly go through recurring waves of workforce reduction. This is especially true when a company is shifting its product portfolio, moving customers off legacy systems, or transitioning to a new technology model. Cost restructuring during a product overhaul is standard practice in the software industry.
Think of it this way: a software company that consolidates its workforce while launching a new cloud-based product can look, from the outside, like it is declining. But internally, that same company might be cutting costs on legacy operations while investing in its next major release. The two things can happen at the same time.
That appears to be the more accurate description of what is happening at Greenway, rather than a company in freefall.
What Is Novare, and Why Does It Matter?
The clearest signal that Greenway is not shutting down is its investment in a new platform called Novare.
According to coverage from Healthcare IT Today, Greenway leadership concluded that the EHR as a category is broken. Rather than layering new features onto fragmented legacy systems, Greenway chose to build a completely new platform from the ground up.
Novare is described as an end-to-end ambulatory platform with AI built into the core design, not added on afterward. The goal is to streamline the full range of practice workflows, from pre-encounter to billing and collections. Greenway leaders have described it as a way to give practices back time, reduce documentation burden, and improve the financial health of the practice.
Companies that are preparing to shut down do not build new platforms. They stop investing. The development of Novare is direct evidence that Greenway is focused on its future, not winding down its present.
That said, the shift to Novare does raise a legitimate question for current users of Intergy and PrimeSUITE: what happens to those legacy products? Practices using older Greenway systems should ask direct questions about support timelines and migration paths. Product transitions are normal in the software industry, but they require planning.
Customer Complaints: Service Issues vs. Company Failure
The Better Business Bureau lists a number of customer complaints against Greenway Health. These center on billing service performance, contract disputes, and customer support issues. One example involves a practice that had used Greenway since 2019, renegotiated its contract in 2022 due to ongoing problems, and continued to experience difficulties afterward.
These complaints are legitimate concerns. They suggest that some customers have had frustrating experiences, particularly with billing services.
But service complaints are common across the EHR industry. They reflect operational problems and areas where a vendor needs to improve. They do not indicate that the company is about to close or that all customers are having poor outcomes.
Practices experiencing issues should document problems, review contract terms carefully, and escalate through formal support channels. Those steps are practical regardless of which EHR vendor a practice uses.
How to Evaluate Any EHR Vendor’s Stability
Greenway’s situation is a useful prompt for thinking about vendor risk more broadly. Here is a simple framework any practice can use:
- Active product development: Is the vendor investing in new features or new platforms? Greenway is, with Novare.
- Ongoing marketing and sales: Is the company seeking new customers and publishing thought leadership? Greenway is doing both.
- Public legal or financial filings: Are there bankruptcy filings, court-ordered wind-downs, or regulatory shutdowns? For Greenway, the answer is no.
- Response to past legal issues: Did the company pay its obligations and implement compliance measures? Greenway did.
- Employee reviews: Useful for texture and context, but not sufficient on their own to conclude a company is closing.
Applying this framework honestly to Greenway produces a picture of a company under pressure and in transition, but not one that is collapsing or disappearing.
Practical Steps for Current Greenway Customers
Even if Greenway is not going out of business, it is smart to take a few protective steps regardless of who your vendor is.
- Review your contract for data export rights and exit clauses. Know what you are entitled to if you ever need to migrate.
- Ask your Greenway representative directly about the support roadmap for your specific product, whether that is Intergy, PrimeSUITE, or another system.
- Start learning about Novare now. If Greenway eventually sunsets legacy platforms in favor of Novare, early awareness gives you more time to plan.
- Maintain regular data backups and understand how your clinical data can be exported if needed.
- Evaluate your overall vendor concentration. If you rely on a single vendor for EHR, billing, and patient communication, a disruption anywhere becomes a disruption everywhere.
These are reasonable steps for any practice to take, not a response to a crisis at Greenway specifically. Daily Business Media regularly covers business stability, vendor risk, and operational planning topics for exactly this reason.
The Bottom Line
Greenway Health is not going out of business. There is no credible evidence of bankruptcy, shutdown, or imminent closure. The company has a meaningful legal and reputational history that deserves acknowledgment, and it is operating in a competitive market while managing recurring internal restructuring. Those are real pressures.
But the company is also actively developing a new platform, continuing to market its services, and publicly engaging with the healthcare IT community about its future direction. None of that is consistent with an organization preparing to close.
The more useful question for current and prospective customers is not whether Greenway is going out of business, but whether it is the right long-term fit for their practice.
Also Read:
